Immunogenic cell death pathway polymorphisms for predicting oxaliplatin efficacy in metastatic colorectal cancer

BACKGROUND: Immunogenic cell death (ICD) is a tumor cell death involving both innate and adaptive immune responses. Given published findings that oxaliplatin, but not irinotecan, drives ICD, we investigated whether single nucleotide polymorphisms (SNPs) in the ICD pathway are associated with the eff...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Immunother Cancer
Asıl Yazarlar: Arai, Hiroyuki, Xiao, Yi, Loupakis, Fotios, Kawanishi, Natsuko, Wang, Jingyuan, Battaglin, Francesca, Soni, Shivani, Zhang, Wu, Mancao, Christoph, Salhia, Bodour, Mumenthaler, Shannon M, Weisenberger, Daniel J, Liang, Gangning, Cremolini, Chiara, Falcone, Alfredo, Millstein, Joshua, Lenz, Heinz-Josef
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMJ Publishing Group 2020
Konular:
Clinical/Translational Cancer Immunotherapy
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7656952/
https://ncbi.nlm.nih.gov/pubmed/33172883
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-001714
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller